Ординатура / Офтальмология / Английские материалы / Ocular Blood Flow and Glaucomatous Optic Neuropathy_Mozaffarieh, Flammer_2009
.pdfFurther reading
The text in this book is based on numerous publications and in order to keep the text concise and readable, individual publications have not been referred to or cited in the text. Instead, the authors direct the reader to their internet homepage: www.glaucomaresearch.ch.
Books published by the Basel Group
Erb C, Flammer J (Eds). Risikofaktoren für augenerkrankungen: bedeutung und behandlung. Bern: Hans Huber Verlag, 1999.
Flammer J. Glaucoma – a guide for patients, an introduction for care-providers, a quick reference. Bern: Hogrefe & Huber, 2006.
Haefliger IO, Flammer J (Eds). Nitric oxide and endothelin in the pathogenesis of glaucoma. Philadelphia: Lippincott Williams & Wilkins, 1998. Kaiser HJ, Flammer J, Hendrickson PH (Eds). Ocular blood flow. Basel: Karger Verlag, 1996.
Kaiser HJ, Flammer J. Gesichtsfeldatlas. Basel: Buser Druck, 1991. Kaiser HJ, Flammer J. Visual field atlas. Basel: Buser Druck, 1999.
Kaiser HJ, Flammer J, Sampaolesi R. Atlas de campo visual. Basel: Buser Druck, 1993.
Prünte CH, Flammer J (Eds). Das glaukom in der praxis. Basel: Karger Verlag, 1997.
Kaiser HJ, Flammer J (Eds). Kinderophthalmologie – auge und allgemeinerkrankungen. Bern: Hans Huber Verlag, 1999.
Orgül S, Flammer J (Eds). Pharmacotherapy in glaucoma. Bern: Hans Huber Verlag, 2000.
Shaarawy T, Flammer J (Eds). Glaucoma therapy: current issues and controversies. London: Martin Dunitz, 2004.
100 • further reading
Flammer J. Glaucoma – a guide for patients, an introduction for care-providers, a quick reference has been published in the following languages:
German, 1st edition (2000) English, 1st edition (2001) German, 2nd edition (2001) Bulgarian edition (2002) Chinese edition (2002) French edition (2002) Italian edition (2002) Czech edition (2003) English, 2nd edition (2003)
English edition for India (2003) Russian edition (2003)
Turkish edition (2003) Arabic edition (2004) Polish edition (2004)
Romanian edition (2004) Spanish, 1st edition (2004) Portuguese edition (2005) English, 3rd edition (2006) Japanese edition (2007) Korean edition (2007) Russian, 2nd edition (2008) Ukrainian edition (2008) Ethiopian edition (in print) Georgian edition (2009)
Serbian–Croatian edition (in print) Spanish, 2nd edition (in print)
Further details on these books as well as information on how to order copies is available at www.glaucomaresearch.ch.
Index
ABC transport proteins 56 acetylcholine 49 achromatic sensitivity 30
adenosine triphosphate (ATP) 56 adrenergic agonists 81
aging glutathione 73
normal tension glaucoma 39 primary open-angle glaucoma 38
AIDS 40, 66
AION see anterior ischemic optic neuropathy Alzheimer’s disease 89
aminoguanidine 84 anaesthetics 49, 51 angiography 18
angle closure glaucoma 35
anterior ischemic optic neuropathy (AION) 40, 64, 65
anthocyanins 94 antioxidants 6, 72, 89, 93 apoptosis 12, 13, 75
arterial hypotension 39, 40–1 arteriosclerosis 3
arthritis 66 astrocytes 71, 75, 81 atherosclerosis 35, 40
ATP see adenosine triphosphate ATP-independent heat production 57 autoimmune diseases 3 autoregulation 41–2, 69, 75, 77
BBB see blood–brain barrier berries 94
bilberries 82, 94 bland atrophy 41, 64 β-blockers 56, 79, 81
blood–brain barrier (BBB) 48
blood flow eye 45–53
optic nerve head 48, 64 regulation 45, 46, 55 velocity 15, 19
blood pressure (BP) 2, 40–1, 42
primary vascular dysregulation 57, 59, 60, 75
see also hypertension; orthostatic hypotension
blood–retinal barrier 19 blueberries 95
body mass index 57 BP see blood pressure bradykinin 49, 51
cacao beans 87, 88
CAIs see carbonic anhydrase inhibitors calcium 48
calcium channel blockers (CCBs) 25, 56, 82, 83, 85–6
carbonic anhydrase inhibitors (CAIs) 81, 85, 86
cardiac output 41, 45, 46 carotid stenosis 40 cataracts 79
catechin 90
CCBs see calcium channel blockers cellular stress 11–13
central serous chorioretinopathy (CSC) 65, 68 cGMP see cyclic guanine monophosphate cholinergic agonists 81
choroid, blood flow 47–8 chromatic sensitivity 30 circadian fluctuation 36 coenzyme Q10 95, 96 coffee 82, 90, 92
102 • INDEX
cold provocation 57
color Doppler imaging 20, 21, 22 comet assay 14–15, 71 congenital glaucoma 35, 36 contrast sensitivity 30
corneal thickness, primary open-angle glaucoma 38
coronary heart disease 92
CSC see central serous chorioretinopathy cup/disc ratio 39
cyclic guanine monophosphate (cGMP) 49, 51
cytokines 73
diabetes 35, 39
diabetic autonomic neuropathy 63 differential light sensitivity (DLS) 22 dipyrimadole 83, 86, 87
disc haemorrhages 30, 31, 34, 39, 78 DLS see differential light sensitivity DNA 13
comet assay 14–15 glaucoma 71
Doppler effect 18–19, 20 dorzolamide 85
drugs 48
intraocular pressure 79, 81, 82 drug sensitivity 56, 58 dyslipidemia 35
dysplasis 13
dysregulation see vascular dysregulation
EDVFs see endothelial-derived vasoactive factors
EGFR see epidermal growth factor receptor electromagnetism 8
electron transport chain (ETC) 9 endosymbiosis 9
endothelial-derived vasoactive factors
(EDVFs) 45, 48, 50
endothelial nitric oxide synthase see nitric oxide synthase
endothelin-1 48, 51, 52, 53, 60 glaucoma 71
inhibition 83
endothelin (ET) 3, 40, 49–50 secondary vascular dysregulation 66
enzymes 48 epicatechin 90
epidermal growth factor receptor (EGFR) 81–2 epigallocatechin 90
ET see endothelin
ETC see electron transport chain evolution 8–9
excitotoxicity 74 exercise 45
fibrin 36 fish 82
FLA see fluorescence angiography flavan-3-ols 87
flavonoids 89 fludrocortisone 80, 84
fluorescence angiography (FLA) 16–18, 31 flux 20
free radicals 5, 10, 87
French paradox 92 fundus photograph 32
gender 39, 61
giant cell arteritis 40, 70 ginkgo biloba 80, 82, 89–90, 91 glaucocorticoids 84
glaucoma
cellular stress 11 epidemiology 28 intraocular pressure 2 ocular blood flow 3 oxidative stress 71–4 prevalence 29
risk factors 35 symptoms 28, 30
glaucomatous optic neuropathy (GON) 2, 7, 27–34
atherosclerosis 40 blood pressure 40–1, 42
Flammer 77, 80 intraocular pressure 80 migraine 62
oxidative stress 87 pathogenesis 75–8 reperfusion injury 70–1 risk factors 36–8
vascular dysregulation 43, 61–3 glial cells 3, 47
activation 31, 33, 78 glutamate 73, 74 glutathione (GSH) 72
GON see glaucomatous optic neuropathy green tea 90
GSH see glutathione
haemorrhages 30, 31, 34, 39, 62, 78 handgrip test 25, 63
heat shock proteins (HSPs) 97–8
Heidelberg RetinalTomograph 31 hemorrhages 30, 31, 34, 39, 62, 78 high tension glaucoma (HTG) 31, 62 hormones 45, 48, 50, 53
HSPs see heat shock proteins HTG see high tension glaucoma hydrogen peroxide 11 hypertension 2, 35
hypotension see orthostatic hypotension hypothalamus 60
hypoxia 11
indoleamines 95 inflammation 52, 55
intraocular pressure (IOP) 1, 35–8 glaucomatous optic neuropathy 80 reduction 79–80, 81, 82 reperfusion injury 69, 75
risk factors 35, 36
IOP see intraocular pressure ischemia 34, 35, 69
juvenile glaucoma 35
kidneys 59
laser Doppler flowmeter (LDF) 20, 21 laser Doppler velocimetry (LDV) 19 laser scan imaging 31
LDF see laser Doppler flowmeter LDV see laser Doppler velocimetry lens luxation 35
light 6–7
lipid peroxidation 72 local anaesthetics 49, 51 lycopene 93–4
macular degeneration 30 magnesium 80, 82, 86
magnetic resonance imaging (MRI) 28 malonylaialdehyde (MDA) 72
matrix metalloproteinase-9 (MMP-9) 71, 78, 97
MCP see 3-methyl-1,2-cyclopentanedione MDA see malonylaialdehyde
mechanical stress
epidermal growth factor receptor 81 primary vascular dysregulation 60, 85
melatonin 82, 95, 96, 97 metalloproteinases 72 metamorphopsia 30
INDEX • 103
metaplasia 13 3-methyl-1,2-cyclopentanedione (MCP) 92 microaneurysma 17
migraine 2, 43
glaucomatous optic neuropathy 62 primary vascular dysregulation 56, 61 vasospasm 62
mineralcorticoid 82 minute volume 45 mitochondria 70, 90
MMP-9 see matrix metalloproteinase-9
MRI see magnetic resonance imaging
Müller cells 73
multiple sclerosis 40, 52, 53, 60, 66 myopia 39
nailfold capillaromicroscopy 22, 23, 26, 57 necrosis 12
nerve fiber layer loss 31, 32 neural cells 47 neuroretinal rim 30 neurotransmitters 73 nifedipine 86
nimodipine 86
nitric oxide (NO) 47, 48–9, 50, 51, 73, 75 nitric oxide synthase (NOS) 48, 81
cacao beans 87 inhibition 83–4
N-methyl-d-aspartate (NMDA) receptors 73–4
NO see nitric oxide nocturnal dips 40
normal tension glaucoma (NTG) 16, 31, 36, 59
risk factors 39, 61, 78
NOS see nitric oxide synthase NTG see normal tension glaucoma
occlusions 16
OCT see optical coherence tomography octopus perimeter 24
ocular hypertension (OHT) 37, 38 ocular perfusion 1, 77
ocular pulse amplitude (OPA) 22 OHT see ocular hypertension omega-3-fatty acids 82, 87, 88 ONH see optic nerve head
OPA see ocular pulse amplitude
optical coherence tomography (OCT) 31, 32 optic disc hemorrhage 30, 31, 34, 39
optic nerve 28, 31
optic nerve excavation 30, 31
104 • INDEX
optic nerve head (ONH) 2, 15, 47 bland atrophy 41
blood flow 48, 64 cupping 75 hemorrhages 62
organ transplantation 69
orthostatic hypotension 40, 59, 70, 78, 84 oxidation 5
oxidative stress 3, 6, 13, 87–97 comet assay 14–15 glaucoma 71–4
glaucomatous optic neuropathy 73 mitochondria 90
reperfusion injury 70, 75 oxygen 5, 7–9
activation 10–11 energy levels 12, 45 reperfusion injury 69
pain killers 58
perfusion pressure (PP) 2 pericytes 45, 49, 66 perimetry 22, 24
peripapillary atrophy 30, 31, 33, 39 peripheral claudication 89 peroxynitrate 75, 76, 92 personality 58
PGI2 see prostacyclin photons 6 photosensibilisation 12 photosynthesis 8
pigmentary dispertion glaucoma 35, 36 platelet aggregation 45
POAG see primary open-angle glaucoma polyarthritis 40
polyphenols 89, 90
PP see perfusion pressure preconditioning 13, 69, 70
primary open-angle glaucoma (POAG) 35–6, 38, 69
primary vascular dysregulation (PVD) 2, 22,
55–68, 78 autoregulation 75, 85 blood pressure 50, 57, 59 emotional stress 60
eye circulation 63–4
glaucomatous optic neuropathy 61–3 mechanical stress 60
mechanisms 56–7 migraine 61 reperfusion injury 70 skin perfusion 58
symptoms 57–8 temperature 59 thirst 57, 60, 61
primary vasospastic syndrome see vasospasm
pro-oxidants 5, 13 prostacyclin (PGI2) 48 prostaglandin analogues 81 proteasomes 13, 71, 73 protein damage 72 provocation tests 25, 26
pseudoexfoliation glaucoma 35, 36
PVD see primary vascular dysregulation
quinones 94–5
radiation 11
reactive oxygen species (ROS) 3, 5, 15, 71 redox reaction 5–6
reperfusion injury 69–74, 75, 87 respiration 8
resveratrol 93 retina 31, 45–7
glial cell activation 33 glutamate 73
primary vascular dysregulation 63 retinal arterial branch occlusion 65, 66 retinal vein occlusion (RVO) 64
retinal vessel analyzer 18, 20
ROS see reactive oxygen species rubeosis 35
RVO see retinal vein occlusion
salt 80, 82
secondary vascular dysregulation (SVD) 66 serotonin 53
shifted light 19
shock-like states 70, 78, 84 Shy–Drager syndrome 63 silent myocardial ischemia 63
single cell gel electrophoresis 14 skin perfusion, primary vascular
dysregulation 58 sleep apnea 70, 78 sleep onset time 58, 59
smooth muscle cells 49, 66 sodium reabsorption 2, 59 splinter hemorrhages 62 stereo photography 31, 32
stress, primary vascular dysregulation 60, 85 Susac syndrome 65, 67
SVD see secondary vascular dysregulation
tea 82, 90, 91, 92 temperature 15–16
primary vascular dysregulation 59, 85 regulation 45, 48
thermography 59 thirst 57, 60, 61 tinnitus 89
TNF see tumor necrosis factor tomatoes 93–4
tumor necrosis factor (TNF) 73
ubiquinone 95 ubiquitin 72 ultrasound 15, 28 uveiitis 35
INDEX • 105
vascular dementia 89
vascular dysregulation 23, 39, 43, 55–68, 85 vascular smooth muscle cells (VSMC) 45 vascular tone 55
vasoconstriction 45, 53 drugs 79
vasodilation 41 vasospasm 55, 62, 86
visual field changes 22–5, 30, 37, 86 vitamins 90
VSMC see vascular smooth muscle cells
wine 82, 92–3
Index compiled by Indexing Specialists (UK) Ltd, www.indexing.co.uk.
